Root Financial Partners’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
Other funds holding DAWN
Root Financial Partners's DAWN Position: Q2 2026 in Review
Root Financial Partners sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 335 shares — an estimated $7.18K sold.
Root Financial Partners first reported a position in DAWN in Q4 2025 and held it in 2 quarters. The position peaked at $7.18K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.
- Root Financial Partners reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Root Financial Partners sold 335 Day One Biopharmaceuticals shares in Q2 2026, an estimated $7.18K.
- Root Financial Partners first reported a position in Day One Biopharmaceuticals in Q4 2025 and held it in 2 quarters.
- Root Financial Partners's Day One Biopharmaceuticals position peaked at $7.18K in Q1 2026.
- 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.
Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.